Allergy & Immunology Doctors in Boys Town, NE Accepting Medicare
3 Allergy & Immunology doctors found. Showing 1 - 3
 Dr. Nigar S Nair, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 14080 Hospital Rd, Boys Town, NE 68010 Phone: 402-778-6900 Fax: 402-778-6917 |
 Dr. Kevin R Murphy, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 14080 Hospital Rd, Boys Town, NE 68010 Phone: 402-778-6900 Fax: 402-778-6917 |
Jill R Hanson, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 14080 Boys Town Hospital, Boys Town National Research Hospital, Boys Town, NE 68010 Phone: 402-778-6900 Fax: 402-778-6917 |
News Archive
Natural plant extract could help treat COPD and inflammatory disorders
A widely and safely used plant extract acts as a novel anti-inflammatory agent that may one day be used for the treatment of chronic obstructive pulmonary disease, or COPD, as well as other inflammatory conditions.
Huddersfield researchers write groundbreaking report on intersex and DSD in the UK
UNIVERSITY of Huddersfield researchers have written a report that calls for a national review of Intersex and DSD medical and social treatment in the UK.
Covidien provides update on its operations in Japan
Covidien, a leading global supplier of healthcare products, today provided an update on its operations in Japan.
GEHC signs MOU with Concord Medical to form preferred strategic partnership in China
Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it has signed an Memorandum of Understating with GE Healthcare, through its subsidiaries General Electric International Operations Company, Inc. and GE Medical Systems Trade & Development Co., Ltd., to form a preferred strategic partnership in China.
Genentech submits BLA for trastuzumab-DM1 in advanced HER2-positive breast cancer
Genentech, a member of the Roche Group, today announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trastuzumab-DM1 (T-DM1) in people with advanced HER2-positive breast cancer who have previously received multiple HER2-targeted medicines and chemotherapies.
› Verified 8 days ago
Pediatrics
Psychiatry & Neurology
Otolaryngology
Internal Medicine
Allergy & Immunology
Orthopaedic Surgery
Anesthesiology
Surgery